InsidersTradesSigma
Discover the full management transaction log of 인바이오, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Basic Materials sector, 인바이오 has published 2 insider filings. Market capitalisation: €24.5bn. The latest transaction was reported on 10 March 2026 — Purchase. Among the most active insiders: 조인선. The full history is accessible without an account.
FY ended December 2025 · cache
0 of 0 declarations